- Provia Laboratories
Grace Century’s Portfolio Project Board Member Asked to Serve on Bahamian Pre-Clearance Stem Cell Et
Dr. James A. Manganello, Board Member of Grace Century’s portfolio stem cell project, Provia Laboratories, LLC, has accepted an invitation to serve on the Bahamian Pre-Clearance Stem Cell Ethics Committee. The Bahamian National Stem Cell Ethics Committee (NSCEC) sets a team in place to review all further applications for a license for all stem cell research activities in The Bahamas.
RAS AL KHAIMAH, UAE (PRWEB) FEBRUARY 12, 2015
Private equity and international research consultancy, Grace Century’s portfolio company, Provia Laboratories, LLC, has announced, just days after the provisional approval of the firms new entrance into the Commonwealth, that Dr. James A. Manganello has been invited to serve on a newly formed “pre-clearance team” for future entities applying for activity in the Caribbean nation.
The purpose of this team, led by Dr. Desiree Cox, Rhodes Scholar, MD, Ph.D., MPhil, is to provide quality control of the stem cell research and stem cell therapy applications submitted to the Bahamian National Stem Cell Ethics Committee.
"This further demonstrates Provia’s leadership in this field. Provia has advised pharmaceutical/biotech companies and consulted on multiple initiatives within the National Institutes of Health (NIH) in the field of biobanking for many years now. The team has established itself as a group of thought leaders in the field of bio-banking and stem cell science,” Scott Wolf, CEO of Grace Century, commented.“
The commonwealth continues to fortify its vision for establishing the nation as a true global force in health care innovations and in the future of the stem cell industry,” Wolf added.
